医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
11期
1419-1420,1423
,共3页
铁蛋白%叶酸%血液系统恶性肿瘤
鐵蛋白%葉痠%血液繫統噁性腫瘤
철단백%협산%혈액계통악성종류
Ferritin%Folate%Hematological malignant disease
目的:探讨血清铁蛋白(Serum ferritin ,SF)、叶酸在血液系统恶性肿瘤患者诊断及预后中的临床价值。方法:采用放免法测定97例血液系统恶性肿瘤患者化疗前、后铁蛋白、叶酸的水平,分别观察对照组、治疗前、治疗后缓解组、部分缓解组及未缓解组血清铁蛋白、叶酸结果,进行组间比较。观察并比较不同铁蛋白水平下疾病的缓解率。结果:所观察的97例患者病程的各阶段均存在不同程度的铁蛋白增高、叶酸减低。尤以治疗前及治疗后未缓解组明显;治疗后完全缓解组SF、叶酸均有明显变化,与治疗前均值相比(P<0.01),但仍未恢复正常水平;经治疗后部分缓解组SF、叶酸与正常对照组及治疗前均值比较均有统计学意义(P<0.01);同时治疗前SF小于600ng/ml的患者常规化疗缓解率明显高于大于600ng/ml的患者(P<0.01)。结论:血清铁蛋白及叶酸可作为血液系统恶性肿瘤学的指标,其测定不仅有助于诊断与预后的判断,还能够初步进行疗效评价,指导化疗方案的选择及调整。
目的:探討血清鐵蛋白(Serum ferritin ,SF)、葉痠在血液繫統噁性腫瘤患者診斷及預後中的臨床價值。方法:採用放免法測定97例血液繫統噁性腫瘤患者化療前、後鐵蛋白、葉痠的水平,分彆觀察對照組、治療前、治療後緩解組、部分緩解組及未緩解組血清鐵蛋白、葉痠結果,進行組間比較。觀察併比較不同鐵蛋白水平下疾病的緩解率。結果:所觀察的97例患者病程的各階段均存在不同程度的鐵蛋白增高、葉痠減低。尤以治療前及治療後未緩解組明顯;治療後完全緩解組SF、葉痠均有明顯變化,與治療前均值相比(P<0.01),但仍未恢複正常水平;經治療後部分緩解組SF、葉痠與正常對照組及治療前均值比較均有統計學意義(P<0.01);同時治療前SF小于600ng/ml的患者常規化療緩解率明顯高于大于600ng/ml的患者(P<0.01)。結論:血清鐵蛋白及葉痠可作為血液繫統噁性腫瘤學的指標,其測定不僅有助于診斷與預後的判斷,還能夠初步進行療效評價,指導化療方案的選擇及調整。
목적:탐토혈청철단백(Serum ferritin ,SF)、협산재혈액계통악성종류환자진단급예후중적림상개치。방법:채용방면법측정97례혈액계통악성종류환자화료전、후철단백、협산적수평,분별관찰대조조、치료전、치료후완해조、부분완해조급미완해조혈청철단백、협산결과,진행조간비교。관찰병비교불동철단백수평하질병적완해솔。결과:소관찰적97례환자병정적각계단균존재불동정도적철단백증고、협산감저。우이치료전급치료후미완해조명현;치료후완전완해조SF、협산균유명현변화,여치료전균치상비(P<0.01),단잉미회복정상수평;경치료후부분완해조SF、협산여정상대조조급치료전균치비교균유통계학의의(P<0.01);동시치료전SF소우600ng/ml적환자상규화료완해솔명현고우대우600ng/ml적환자(P<0.01)。결론:혈청철단백급협산가작위혈액계통악성종류학적지표,기측정불부유조우진단여예후적판단,환능구초보진행료효평개,지도화료방안적선택급조정。
Objective :To investigate the clinical value of serum ferritin (SF) and folate detection in the diagnosis and prognosis judgment of the patients with hematological malignant disease .Methods :Adopt radioimmunoassay to detect serum ferritin and folate of 97 patients with hematological malignancies in different period ,serum ferritin and folate were observed separately in control group ,no-treatment group ,remission group ,Partial remission group and non-remis-sion group ,these results are compared between groups .To observe and compare the remission rate of disease in differ-ent ferritin level .Results:There are different degrees of serum ferritin increase and folate reduce in every stage of the 97 patients with hematological malignant tumor patients observed .Especially in no-treatment group and non-remission group;complete remission group have obvious changes in SF and folate ,Compared with before treatment (P<0.01) , but not back to normal ;Partial remission group compared with before treatment and control (P<0 .01);patients with lower SF(<600ng/L) acquired higher remission rate than others (P<0 .01).Conclusion:Serum ferritin and folate can be used as indicators of hematological malignant disease ,they are helpful not only to diagnosis and prognosis ,also to preliminary efficacy evaluation.Serum ferritin and folate are benefit to doctor in formulation and adjustment of chemo-therapy.